Junker, D., Becker, M., Wagner, T. R., Kaiser, P. D., Maier, S., Grimm, T. M., Griesbaum, J., Marsall, P., Gruber, J., Traenkle, B., Heinzel, C., Pinilla, Y. T., Held, J., Fendel, R., Kreidenweiss, A., Nelde, A., Maringer, Y., Schroeder, S., Walz, J. S., Althaus, K., Uzun, G., Mikus, M., Bakchoul, T., Schenke-Layland, K., Bunk, S., Haeberle, H., Göpel, S., Bitzer, M., Renk, H., Remppis, J., Engel, C., Franz, A. R., Harries, M., Kessel, B., Lange, B., Strengert, M., Krause, G., Zeck, A., Rothbauer, U., Dulovic, A., & Schneiderhan-Marra, N. (2023). antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants. Clinical infectious diseases, 76, e240–e249. http://access.bl.uk/ark:/81055/vdc_100177574619.0x00001a